SANOFI.BO
SANOFI.BO
INE058A01010
SANOFI INDIA LTD
Loading chart...

Company Profile

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.

Related stocks

SANOFICONR.NS
SANOFICONR.NS • India
SANOFI CONS HEALTHC IND L
3,581.7 INR
853.55M USD 1Y -24.8%
PFIZER.NS
PFIZER.NS • India
PFIZER LTD
3,808.2 INR
1.8B USD 1Y -27.7%
RUBICON.NS
RUBICON.NS • India
RUBICON RESEARCH LIMITED
1,548.5 INR
2.65B USD
600713.SS
600713.SS • China
NANJING PHARMACEUTICAL GP CO LT
5.14 CNY
1.01B USD 1Y +3.6%
600771.SS
600771.SS • China
GUANGYUYUAN CHINESE HERBAL MEDI
14.38 CNY
1.05B USD 1Y -24.5%
300181.SZ
300181.SZ • China
ZUO LI YAO YE
13.25 CNY
1.39B USD 1Y -25.8%
GLAXO.NS
GLAXO.NS • India
GLAXOSMITHKLINE PHARMA LT
2,540.3 INR
4.45B USD 1Y -8%
H02.SI
H02.SI • Singapore
Haw Par
12.77 SGD
2.21B USD 1Y -13.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
26.6% p.a.
Max Drawdown (5Y)
-70.3%
Sharpe Ratio (5Y)
-0.77
Beta Factor
0.16
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Historical Stress Test: Maximum peak-to-trough drawdown of -70.3% in the extended horizon.
ende